Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J. +7 more·2016·Nature Communications

Cited by (1,003)

Items 301–400 of 1,003

  1. Immune regulation by monocytes
    Peter J. Murray · 2017 · Seminars in Immunology
  2. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
    Takenori Uehara, Shingo Eikawa, Mikako Nishida, Yuki Kunisada, Aki Yoshida, Tomohiro Fujiwara, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono · 2018 · International Immunology
  3. The Generation and Identity of Human Myeloid-Derived Suppressor Cells
    Caroline Bergenfelz, Karin Leandersson · 2020 · Frontiers in Oncology
  4. The Contribution of the Immune System in Bone Metastasis Pathogenesis
    Lisha Xiang, Daniele M. Gilkes · 2019 · International Journal of Molecular Sciences
  5. Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma
    Muthulekha Swamydas, Elena V. Murphy, James John Ignatz-Hoover, Ehsan Malek, James Joseph Driscoll · 2022 · Journal of Hematology & Oncology
  6. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
    Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, Abubakar Nazir, Gafar Babatunde Bamigbade, Narjiss Aji, Poulami Roy, Hajar kachani, Neil K. Garg, Lukman Lawal et al. · 2024 · European journal of medical research
  7. Leukocyte trafficking in tumor microenvironment
    Annalisa Del Prete, Tiziana Schioppa, Laura Tiberio, Helena Stabile, Silvano Sozzani · 2017 · Current Opinion in Pharmacology
  8. Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
    Jason Alan Chesney, Robert A. Mitchell, Kavitha Yaddanapudi · 2017 · Journal of Leukocyte Biology
  9. Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation
    Scott J. Denstaedt, Benjamin H. Singer, Theodore J. Standiford · 2018 · Frontiers in Immunology
  10. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
    Sara Falck‐Jones, Sindhu Vangeti, Meng Yu, Ryan Falck‐Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Åhlberg, Ang Lin et al. · 2021 · Journal of Clinical Investigation
  11. Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors
    Peng Ouyang, Lijuan Wang, Jianlong Wu, Yao Tian, Caiyun Chen, Dengsheng Li, Zengxi Yao, Ruichang Chen, Guoan Xiang, Jin Gong et al. · 2024 · Frontiers in Immunology
  12. Myeloid derived-suppressor cells: their role in cancer and obesity
    Suzanne Ostrand‐Rosenberg · 2018 · Current Opinion in Immunology
  13. Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
    David M. Peereboom, Tyler Joseph Alban, Matthew M. Grabowski, Alvaro G. Alvarado, Balint Otvos, Defne Bayık, Gustavo A. Roversi, Mary McGraw, Pengjing Huang, Alireza Mohammad Mohammadi et al. · 2019 · JCI Insight
  14. Ascites-derived IL-6 and IL-10 synergistically expand CD14+HLA-DR-/low myeloid-derived suppressor cells in ovarian cancer patients
    Liangliang Wu, Zhaoyang Deng, Yaojun Peng, Lu Han, Jing Liu, Linxiong Wang, Bohua Li, Jian Zhao, Shunchang Jiao, Huafeng Wei · 2017 · Oncotarget
  15. Endoplasmic reticulum stress induced LOX‐1+ CD 15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma
    Jiang Nan, Yan‐Fang Xing, Bo Hu, Jian‐Xin Tang, Huimin Dong, Yu‐Mei He, Dan‐Yun Ruan, Qing‐Jian Ye, Jia‐Rong Cai, Xiaokun Ma et al. · 2017 · Immunology
  16. Role of Tumor-Associated Myeloid Cells in Breast Cancer
    Yoon Jin Cha, Ja Seung Koo · 2020 · Cells
  17. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen-induced lung cancer and determines the efficacy of immunotherapy
    Chia-Hsin Liu, Zhong Chen, Kong Chen, Fu-Tien Liao, Chia-En Chung, Xiao-Ping Liu, Yu-Chun Lin, P. Keohavong, G. Leikauf, Y. Di · 2020 · Cancer Research
  18. PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment
    Natalie Bucheimer Collins, Rose Al Abosy, Brian C. Miller, Kevin Bi, Qihong Zhao, Michael M. Quigley, Jeffrey Joseph Ishizuka, Kathleen B. Yates, Hans W. Pope, Robert T. Manguso et al. · 2022 · Journal for ImmunoTherapy of Cancer
  19. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
    Yue Yin, Weibo Feng, Jie Chen, Xilang Chen, Guodong Wang, Shuai Wang, Xiao Xu, Yongzhan Nie, Daiming Fan, Kaichun Wu et al. · 2024 · Experimental Hematology and Oncology
  20. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
    Alessandra Sacchi, Germana Grassi, Veronica Bordoni, Patrizia Lorenzini, Eleonora Cimini, Rita Casetti, Eleonora Tartaglia, Luisa Marchioni, Nicola Petrosillo, Fabrizio Palmieri et al. · 2020 · Cell Death and Disease
  21. Multicenter Systems Analysis of Human Blood Reveals Immature Neutrophils in Males and During Pregnancy
    Jana Blažková, Sarthak Gupta, Yudong Liu, Brice L Gaudilliere, Edward A. Ganio, Christopher R. Bolen, Ron Saar Dover, Gabriela K. Fragiadakis, Martin S. Angst, Sarfaraz Hasni et al. · 2017 · The Journal of Immunology
  22. Neutrophils in COVID-19: Not Innocent Bystanders
    Ellen McKenna, Richard Wubben, Johana M. Isaza-Correa, Ashanty M. Melo, Aisling Ui Mhaonaigh, Niall P. Conlon, James S. O’Donnell, Clíona Ní Cheallaigh, Tim Hurley, Nigel J. Stevenson et al. · 2022 · Frontiers in Immunology
  23. Anti‐PD‐1/PD‐L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer
    V. Gunda, B. Gigliotti, Tameem Ashry, Dorothy Ndishabandi, M. McCarthy, Zhiheng Zhou, S. Amin, Kyu Eun Lee, T. Stork, L. Wirth et al. · 2019 · International Journal of Cancer
  24. c-Rel is a myeloid checkpoint for cancer immunotherapy
    Ting Li, Xinyuan Li, Ali Zamani, Wei Wang, Chin‐Nien Lee, Mingyue Li, George Luo, Emily Eiler, Honghong Sun, Sankar Ghosh et al. · 2020 · Nature Cancer
  25. Long noncoding RNA: a dazzling dancer in tumor immune microenvironment
    Yalu Zhang, Qiaofei Liu, Quan Liao · 2020 · Journal of Experimental & Clinical Cancer Research
  26. Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas
    Yi Wang, Qing Sun, Yun Zhang, Xuelian Li, Qingtao Liang, Ru Guo, Li‐Qun Zhang, Xiqin Han, Jing Wang, Lingling Shao et al. · 2023 · Journal of Infection
  27. Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking
    Alessandro Porrello, Patrick L. Leslie, Emily B. Harrison, Balachandra K. Gorentla, Sravya Kattula, Subrata Kumar Ghosh, Salma H. Azam, Alisha Holtzhausen, Yvonne L. Chao, Michele C. Hayward et al. · 2018 · Nature Communications
  28. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
    Francesca Maria Consonni, Chiara Porta, Arianna Marino, Chiara Pandolfo, Silvia Mola, Augusto Bleve, Antonio Sica · 2019 · Frontiers in Immunology
  29. Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis
    McKenzie K. Hollen, Julie A. Stortz, Dijoia B. Darden, Marvin L. S. Dirain, Dina C. Nacionales, Russell B. Hawkins, Michael C. Cox, Maria-Cecilia Lopez, Jaimar C. Rincon, Ricardo F. Ungaro et al. · 2019 · Critical Care
  30. The colorectal cancer immune microenvironment and approach to immunotherapies
    Minoru Koi, John M. Carethers · 2017 · Future Oncology
  31. Myeloid-Derived Suppressor Cells in Colorectal Cancer
    Izabela Siemińska, Jarek Baran · 2020 · Frontiers in Immunology
  32. Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
    Zhangzuo Li, Qi Wang, Xu‐Feng Huang, Mengting Yang, Shujing Zhou, Zhengrui Li, Zhengzou Fang, Yidan Tang, Qian Chen, Hanjin Hou et al. · 2023 · Frontiers in Nutrition
  33. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
    Sabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, Nadia Castioni, Paola Portararo, Alessandro Gulino, Laura Botti, Mariella Parenza, Barbara Cappetti, Rosaria Orlandi et al. · 2016 · Cell Reports
  34. Perturbation of the Monocyte Compartment in Human Obesity
    Kathleen Friedrich, Miriam Sommer, Sarah Strobel, Stephan Thrum, Matthias Blüher, Ulf G. Wagner, Manuela Rossol · 2019 · Frontiers in Immunology
  35. Tumor microenvironment in head and neck squamous cell carcinoma: Functions and regulatory mechanisms
    Ganping Wang, Ming Zhang, Maosheng Cheng, Xiaochen Wang, Kang Li, Jianwen Chen, Zhi Chen, Shuang Chen, Jie Chen, Gan Xiong et al. · 2021 · Cancer Letters
  36. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
    Feyza Gül Özbay Kurt, Samantha Lasser, Ihor Arkhypov, Jochen Sven Utikal, Viktor Umansky · 2023 · Journal of Clinical Investigation
  37. Targeting myeloid-derived suppressor cells for cancer immunotherapy
    Yijun Liu, Guo‐Wei Wei, Wesley A. Cheng, Zhenyuan Dong, Han Sun, Vincent Y. Lee, Soung-chul Cha, Diane Lynne Smith, Larry W. Kwak, Hong Qin · 2018 · Cancer Immunology Immunotherapy
  38. Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
    Mahnaz Janghorban, Li Xin, Jeffrey M. Rosen, Xiang H.-F. Zhang · 2018 · Frontiers in Immunology
  39. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells
    David K. Edwards V, Kevin Watanabe‐Smith, Angela Rofelty, Alisa Damnernsawad, Ted Laderas, Adam J. Lamble, Evan F. Lind, Andy J. Kaempf, Motomi Mori, Mara W. Rosenberg et al. · 2018 · Blood
  40. Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer
    Peiwen Ma, Pamela L. Beatty, John McKolanis, Randal E. Brand, Robert E. Schoen, Olivera J. Finn · 2019 · Frontiers in Immunology
  41. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
    Ni Li, Qiuli Liu, Ying Han, Siyu Pei, Bisheng Cheng, Junyu Xu, Xiang Miao, Qiang Pan‐Hammarström, Hanling Wang, Jiacheng Guo et al. · 2022 · Nature Communications
  42. Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma
    Li, Meiyi, Wang, Lina, Cong, Liang, Wong, Chi Chun, Zhang, Xiang, Chen, Huarong, Zeng, Tao, Li, Bin, Jia, Xian, Huo, Jihui et al. · 2024 · Hepatology
  43. Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC
    Tang, Kwan Ho, Li, Shuai, Khodadadi-Jamayran, Alireza, Jen, Jayu, Han, Han, Guidry, Kayla, Chen, Ting, Hao, Yuan, Fedele, Carmine, Zebala, John A. et al. · 2022 · Cancer Discovery
  44. Myeloid-derived suppressor cells and their role in pancreatic cancer
    Matthew Pergamo, George Miller · 2016 · Cancer Gene Therapy
  45. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019
    Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, Germana Grassi, Eleonora Tartaglia, Rita Casetti, Maria Letizia Giancola, Nazario Bevilacqua, Markus J. Maeurer et al. · 2020 · Clinical Infectious Diseases
  46. A Milestone Review on How Macrophages Affect Tumor Growth
    Christophe Caux, Rodrigo Nalio Ramos, George C. Prendergast, Nathalie Bendriss‐Vermare, Christine Ménétrier‐Caux · 2016 · Cancer Research
  47. Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
    Jing Chen, Hong-Wei Sun, Yanyan Yang, Haitian Chen, Xing-Juan Yu, Wenchao Wu, Yi-Tuo Xu, Li-Lian Jin, Xiaojun Wu, Jing Xu et al. · 2021 · Signal Transduction and Targeted Therapy
  48. Myeloid-Derived Suppressor Cells in Solid Tumors
    Tianmiao Ma, Bernhard Willibald Renz, Matthias Ilmer, Dominik Thomas Koch, Yuhui Yang, Jens Werner, Alexandr V. Bazhin · 2022 · Cells
  49. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal–fetal tolerance in mice
    Suzanne Ostrand‐Rosenberg, Pratima Sinha, Chas Figley, Ramses Long, DoHwan Park, Darryl Carter, Virginia K. Clements · 2016 · Journal of Leukocyte Biology
  50. Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
    Oscar E. Brück, Sami Blom, Olli Dufva, Riku Turkki, Himanshu Chheda, Antonio Ribeiro, Panu E. Kovanen, Tero A. Aittokallio, Perttu Koskenvesa, Olli Kallioniemi et al. · 2018 · Leukemia
  51. Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway
    Wanwei Zheng, Huan Song, Zhongguang Luo, Hao Wu, Lin Chen, Yuedi Wang, Haoshu Cui, Yufei Zhang, Bangting Wang, Wenshuai Li et al. · 2021 · Proceedings of the National Academy of Sciences
  52. Prostaglanin-E2 Potentiates the Suppressive Functions of Human Mononuclear Myeloid-Derived Suppressor Cells and Increases Their Capacity to Expand IL-10-Producing Regulatory T Cell Subsets
    Sergej Tomić, Bojan Joksimović, Marina Bekić, Miloš Vasiljević, Marijana Milanović, Miodrag J Čolić, Dragana Vučević · 2019 · Frontiers in Immunology
  53. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process
    Antero Salminen, Kai Kaarniranta, Anu Kauppinen · 2018 · Ageing Research Reviews
  54. Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
    Nicholas C. DeVito, Michael P. Plebanek, Bala Theivanthiran, Brent Allen Hanks · 2019 · Frontiers in Immunology
  55. The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
    César U. Monjarás-Ávila, Ana C. Lorenzo‐Leal, Ana Cecilia Luque-Badillo, Ninadh Malrina D’Costa, Claudia I. Chavez-Munoz, Horacio Bach · 2023 · International Journal of Molecular Sciences
  56. Myeloid‐derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy
    Zhongnan Yin, Chunxiao Li, Junjie Wang, Lixiang Xue · 2018 · International Journal of Cancer
  57. The Pseudogene Olfr29-ps1 Promotes the Suppressive Function and Differentiation of Monocytic MDSCs
    Wencong Shang, Yunhuan Gao, Zhenzhen Tang, Yuan Zhang, Rongcun Yang · 2019 · Cancer Immunology Research
  58. Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
    Brendan D. Curti, Yoshinobu Koguchi, Rom S. Leidner, Annah S. Rolig, Elizabeth R. Sturgill, Zhaoyu Sun, Yaping Wu, Venkatesh Rajamanickam, Brady M. Bernard, Ian Hilgart-Martiszus et al. · 2021 · Journal for ImmunoTherapy of Cancer
  59. GZMKhigh CD8+ T effector memory cells are associated with CD15high neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
    Silvia Tiberti, Carlotta Catozzi, Ottavio Croci, Mattia Ballerini, Danilo Cagnina, Chiara Soriani, Caterina Scirgolea, Zheng Gong, Jia-Tai He, Angeli D.G. Macandog et al. · 2022 · Nature Communications
  60. Immune cells as tumor drug delivery vehicles
    Francis Combes, Evelyne Meyer, Niek N. Sanders · 2020 · Journal of Controlled Release
  61. Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression
    Anke Werner, Miriam Koschke, Nadine Leuchtner, Claudia Luckner‐Minden, Alice Habermeier, Johanna Rupp, Christin Heinrich, Roland Conradi, Ellen Ildicho Closs, Markus Munder · 2017 · Frontiers in Immunology
  62. Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
    Stefania Orecchioni, Giovanna Talarico, Valentina Labanca, Angelica Calleri, Patrizia Mancuso, Francesco Bertolini · 2018 · British Journal of Cancer
  63. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease
    Cindy Barnig, Tjitske Bezema, Philip C. Calder, Anne Charloux, Nelly Frossard, Johan Garssen, Oliver Haworth, Ksenia Dilevskaya, Francesca Levi‐Schaffer, Evelyne Lonsdorfer‐Wolf et al. · 2019 · Frontiers in Immunology
  64. Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
    Augusto Bleve, Barbara Durante, Antonio Sica, Francesca Maria Consonni · 2020 · International Journal of Molecular Sciences
  65. 27-Hydroxycholesterol acts on myeloid immune cells to induce T cell dysfunction, promoting breast cancer progression
    Ma, Liqian, Wang, Lawrence, Nelson, Adam T., Han, Chaeyeon, He, Sisi, Henn, Madeline A., Menon, Karan, Chen, Joy J., Baek, Amy E., Vardanyan, Anna et al. · 2020 · Cancer Letters
  66. Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
    Richard P. Tobin, Dasha T. Cogswell, Victoria M. Cates, Dana M. Davis, Jessica S.W. Borgers, Robert J. Van Gulick, Elizabeth N. Katsnelson, Kasey L. Couts, Kimberly Rae Jordan, Dexiang Gao et al. · 2022 · Clinical Cancer Research
  67. Targeting the Tumor Microenvironment of Leukemia and Lymphoma
    Uta E. Höpken, Armin Rehm · 2019 · Trends in cancer
  68. Notch-mediated lactate metabolism regulates MDSC development through the Hes1/MCT2/c-Jun axis.
    Jun-Long Zhao, Yuchen Ye, Chun-Chen Gao, Liang Wang, Kaikai Ren, Ru Jiang, Si-Jun Hu, Shi-Qian Liang, Jian Bai, Jia-Long Liang et al. · 2022 · Cell Reports
  69. Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrow
    Roussel, Mikael, Ferrell, P Brent, Greenplate, Allison R, Lhomme, Faustine, Le Gallou, Simon, Diggins, Kirsten E, Johnson, Douglas B, Irish, Jonathan M · 2017 · Journal of Leukocyte Biology
  70. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
    Karolina Okła, Arkadiusz Czerwonka, Anna Wawruszak, Marcin Stanisław Bobiński, Monika Bilska, Rafał Tarkowski, Wiesława Bednarek, Iwona Wertel, Jan Kotarski · 2019 · Frontiers in Immunology
  71. Autophagy, the innate immune response and cancer
    Chelsea Gerada, Kevin M. Ryan · 2020 · Molecular Oncology
  72. Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
    Tianhang Li, Tianyao Liu, Wenjie Zhu, Shangxun Xie, Zihan Zhao, Baofu Feng, Hongqian Guo, Rong Yang · 2021 · Clinical Medicine Insights Oncology
  73. CD8 + T cell exhaustion in anti‐tumour immunity: The new insights for cancer immunotherapy
    Yijin Huang, Anna Jia, Yufei Wang, Guangwei Liu · 2022 · Immunology
  74. The Endless Saga of Monocyte Diversity
    Stefania Canè, Stefano Ugel, Rosalinda Trovato, Ilaria Marigo, Francesco De Sanctis, Silvia Sartoris, Vincenzo Bronte · 2019 · Frontiers in Immunology
  75. Monocyte metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance
    Kelsey J. Yamada, Cortney E. Heim, Xinyuan Xi, Kuldeep Singh Attri, Dezhen Wang, Wenting Zhang, Pankaj K. Singh, Tatiana K. Bronich, Tammy Kielian · 2020 · PLoS Pathogens
  76. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
    Cristina Zalfa, Silke Paust · 2021 · Frontiers in Immunology
  77. The Key Role of Exosomes on the Pre-metastatic Niche Formation in Tumors
    Xuyang Yang, Yang Zhang, Yaguang Zhang, Su Zhang, Lei Qiu, Zixuan Zhuang, Mingtian Wei, Xiangbing Deng, Ziqiang Wang, Junhong Han · 2021 · Frontiers in Molecular Biosciences
  78. G-CSF, the guardian of granulopoiesis
    Hrishikesh Mehta, Seth Joel Corey · 2021 · Seminars in Immunology
  79. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment
    Vickman, Renee E., Broman, Meaghan M., Lanman, Nadia A., Franco, Omar E., Sudyanti, Putu Ayu G., Ni, Yang, Ji, Yuan, Helfand, Brian T., Petkewicz, Jacqueline, Paterakos, Michael C. et al. · 2020 · The Prostate
  80. Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity
    Tai, Lee-Hwa, Alkayyal, Almohanad A., Leslie, Amanda L., Sahi, Shalini, Bennett, Sean, Tanese de Souza, Christiano, Baxter, Katherine, Angka, Leonard, Xu, Rebecca, Kennedy, Michael A. et al. · 2018 · OncoImmunology
  81. Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
    Jessica C. Hassel, Huanhuan Jiang, Carolin Bender, Julia Katharina Winkler, Alexandra Sevko, Ivan Shevchenko, Niels Halama, Antonia Dimitrakopoulou‐Strauss, Walter E. Haefeli, Dirk Jäger et al. · 2017 · OncoImmunology
  82. A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
    Rebecca Epperly, Stephen M Gottschalk, Mireya Paulina Velasquez · 2020 · Frontiers in Oncology
  83. Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
    Sabbir Khan, Sandeep Mittal, Kain McGee, Kristin D. Alfaro-Munoz, Nazanin Majd, Veerakumar Balasubramaniyan, John de Groot · 2020 · International Journal of Molecular Sciences
  84. Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
    Zhaonian Hao, Ruyuan Li, Yuanyuan Wang, Shuangying Li, Zhenya Hong, Zhiqiang Han · 2021 · Biomarker Research
  85. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression
    Ren-qi Yao, Chao Ren, Liyu Zheng, Zhaofan Xia, Yong-ming Yao · 2022 · Frontiers in Immunology
  86. SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
    Anthos Christofides, Xanthi-Lida Katopodi, Carol Cao, Dimitra Karagkouni, Konstantinos Aliazis, Sasitorn Yenyuwadee, Halil‐Ibrahim Aksoylar, Rinku Pal, Mohamed A. A. Mahmoud, Laura Strauss et al. · 2022 · Nature Immunology
  87. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis
    Cantoni, Claudia, Cignarella, Francesca, Ghezzi, Laura, Mikesell, Bob, Bollman, Bryan, Berrien-Elliott, Melissa M., Ireland, Aaron R., Fehniger, Todd A., Wu, Gregory F., Piccio, Laura · 2017 · Acta Neuropathologica
  88. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells
    Chorong Lee, Wongeun Lee, Steve K. Cho, Sung‐Gyoo Park · 2018 · International Journal of Molecular Sciences
  89. The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction
    Benjamin T. Himes, Timothy E. Peterson, Tristan de Mooij, Luz Milbeth Cumba Garcia, Mi-Yeon Jung, Sarah A. Uhm, David Z. Yan, Jasmine Tyson, Helen J. Jin‐Lee, Daniel Parney et al. · 2020 · Neuro-Oncology
  90. Efficacy of vaccination with tumor-exosome loaded dendritic cells combined with cytotoxic drug treatment in pancreatic cancer
    Li Xiao, Ulrike Erb, Kun Zhao, Thilo Hackert, Margot Zöller · 2017 · OncoImmunology
  91. Aurora A inhibition eliminates myeloid cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in breast cancer
    Yin, Tingting, Zhao, Zhi-Bin, Guo, Jing, Wang, Tianchen, Yang, Jing-Bo, Wang, Chao, Long, Jie, Ma, Shisong, Huang, Qiang, Zhang, Kaiguang et al. · 2019 · Cancer Research
  92. Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
    Mithunah Krishnamoorthy, Lara Gerhardt, Saman Maleki Vareki · 2021 · Cells
  93. Targeting tumour-intrinsic N 7 -methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy
    Hai‐Ning Liu, Xuezhen Zeng, Xuxin Ren, Yifan Zhang, Manling Huang, Li Tan, Zihao Dai, Jiaming Lai, Wenxuan Xie, Zebin Chen et al. · 2022 · Gut
  94. Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade
    Haoran Zha, Xiao Han, Ying Jie Zhu, Fei Yang, Yongsheng Li, Qijing Li, Bo Guo, Bo Zhu · 2017 · OncoImmunology
  95. CCR5 Directs the Mobilization of CD11b+Gr1+Ly6Clow Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development
    Elias Hawila, Hila Razon, Gizi Wildbaum, C Blattner, Yair Sapir, Yuval Shaked, Viktor Umansky, N Karin · 2017 · Cell Reports
  96. IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor Cells
    Wei Lie Xiao, John David Klement, Chunwan Lu, Mohammed L. Ibrahim, Kebin Liu · 2018 · The Journal of Immunology
  97. MDSC subtypes and CD39 expression on CD8 + T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
    Jiae Koh, Youjin Kim, Kyoung Young Lee, Joon Young Hur, Mi Soon Kim, Boram Kim, Hee Jin Cho, Yeong Chan Lee, Yeon Hee Bae, Bo Mi Ku et al. · 2020 · European Journal of Immunology
  98. Inhibition of arginase modulates T-cell response in the tumor microenvironment of lung carcinoma
    Anna Sosnowska, Justyna Chlebowska, Paweł Matryba, Zofia Pilch, Alan Greig, Artur Wolny, Tomasz M. Grzywa, Zuzanna Rydzyńska, Olga Sokołowska, Tomasz P. Rygiel et al. · 2021 · OncoImmunology
  99. The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer
    Jiacheng He, Xiaolei Chai, Qiansen Zhang, Yang Wang, Yijie Wang, Xinyu Yang, Jingbo Wu, Bo Feng, Jing Ping Sun, Weiwei Rui et al. · 2025 · Nature Immunology
  100. Hedgehog Signaling Links Chronic Inflammation to Gastric Cancer Precursor Lesions
    Juanita L. Merchant, Lin Ding · 2017 · Cellular and Molecular Gastroenterology and Hepatology